Literature DB >> 20399948

Contraceptive efficacy of emergency contraception with levonorgestrel given before or after ovulation.

Gabriela Noé1, Horacio B Croxatto, Ana María Salvatierra, Verónica Reyes, Claudio Villarroel, Carla Muñoz, Gabriela Morales, Anita Retamales.   

Abstract

BACKGROUND: We aimed to evaluate whether emergency contraception with levonorgestrel (LNG-EC) administered after ovulation is equally effective to LNG-EC administered before ovulation. STUDY
DESIGN: We studied a cohort of women attending a family planning clinic for EC. From interview, we recorded menstrual history, time of intercourse and of intake of LNG-EC. On the day of intake of LNG-EC and during 5 days' follow-up, blood samples were taken for examination of luteinizing hormone, estradiol and progesterone concentrations, and vaginal ultrasound examinations were done for size of the leading follicle and/or corpus luteum. Thereafter women were not contacted until next menses or pregnancy occurred.
RESULTS: Of 388 women attending for LNG-EC, 122 women had intercourse on fertile cycle days according to ultrasound and endocrine findings. At the time of LNG-EC intake, 87 women were in Days -5 to -1 and 35 women were in Day 0 (day of ovulation) or beyond. With the use of the probability of clinical pregnancy reported by Wilcox et al. [N Engl J Med 333 (1995) 1517-1521], expected numbers of pregnancies among the 87 and 35 women were 13 and 7, respectively, while 0 and 6 pregnancies, respectively, occurred.
CONCLUSION: We conclude that LNG-EC prevents pregnancy only when taken before fertilization of the ovum has occurred.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20399948     DOI: 10.1016/j.contraception.2009.12.015

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  9 in total

Review 1.  Mechanism of action of levonorgestrel emergency contraception.

Authors:  Chris Kahlenborn; Rebecca Peck; Walter B Severs
Journal:  Linacre Q       Date:  2015-02

2.  Appreciation for analysis of how levonorgestrel works and reservations with the use of meloxicam as emergency contraception.

Authors:  A Patrick Schneider; Christopher Kubat; Christine M Zainer
Journal:  Linacre Q       Date:  2016-02

3.  Levonorgestrel in cases of rape: How does it work?

Authors:  Kathleen Mary Raviele
Journal:  Linacre Q       Date:  2014-05

4.  Efficacy and safety of a levonorgestrel enteric-coated tablet as an over-the-counter drug for emergency contraception: a Phase IV clinical trial.

Authors:  Q-J Chen; W-P Xiang; D-K Zhang; R-P Wang; Y-F Luo; J-Z Kang; L-N Cheng
Journal:  Hum Reprod       Date:  2011-06-13       Impact factor: 6.918

5.  In vitro assessment of some sperm function following exposure to levonorgestrel in human fallopian tubes.

Authors:  Alexia Hermanny; M Valeria Bahamondes; Francisco Fazano; Nadia M Marchi; Maria Elena Ortiz; Maria Heloisa R R Genghini; Horacio B Croxatto; Luis Bahamondes
Journal:  Reprod Biol Endocrinol       Date:  2012-01-30       Impact factor: 5.211

Review 6.  Emerging options for emergency contraception.

Authors:  Atsuko Koyama; Laura Hagopian; Judith Linden
Journal:  Clin Med Insights Reprod Health       Date:  2013-02-18

7.  Emergency contraception: an updated review.

Authors:  M Guida; M L Marra; V Palatucci; R Pascale; F Visconti; F Zullo
Journal:  Transl Med UniSa       Date:  2011-10-17

8.  A tiered analytical approach for investigating poor quality emergency contraceptives.

Authors:  María Eugenia Monge; Prabha Dwivedi; Manshui Zhou; Michael Payne; Chris Harris; Blaine House; Yvonne Juggins; Peter Cizmarik; Paul N Newton; Facundo M Fernández; David Jenkins
Journal:  PLoS One       Date:  2014-04-18       Impact factor: 3.240

Review 9.  A systematic review of effectiveness and safety of different regimens of levonorgestrel oral tablets for emergency contraception.

Authors:  Mohammad Shohel; Mohammad Mahfuzur Rahman; Asif Zaman; Mir Muhammad Nasir Uddin; Md Mamun Al-Amin; Hasan Mahmud Reza
Journal:  BMC Womens Health       Date:  2014-04-04       Impact factor: 2.809

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.